May 20, 2016
Gilead Sciences to Present at the UBS Global Healthcare Conference on Monday, May 23
Webcast Available Through Gilead Corporate Website
FOSTER CITY, Calif.--(BUSINESS WIRE)--May 20, 2016--
Gilead Sciences, Inc. (Nasdaq: GILD) today announced that its corporate
presentation will be webcast from the UBS Global Healthcare Conference
in New York.
Norbert W. Bischofberger, Gilead’s Executive Vice President, R&D and
Chief Scientific Officer, will provide an overview of the company at the
conference on Monday, May 23 at 9:30 a.m. Eastern Time.
The live webcast can be accessed at the company’s Investors page at www.gilead.com/investors.
Please connect to the company’s website at least 15 minutes prior to the
start of the presentation to ensure adequate time for any software
download that may be required to listen to the webcast. The replay will
be available for 14 days following the presentation.
About Gilead
Gilead Sciences is a biopharmaceutical company that discovers, develops
and commercializes innovative therapeutics in areas of unmet medical
need. The company’s mission is to advance the care of patients suffering
from life-threatening diseases. Gilead has operations in more than 30
countries worldwide, with headquarters in Foster City, California.
For more information on Gilead Sciences, please visit the company’s
website at www.gilead.com,
follow Gilead on Twitter (@GileadSciences) or call Gilead Public Affairs
at 1-800-GILEAD-5 or 1-650-574-3000.
View source version on businesswire.com: http://www.businesswire.com/news/home/20160520005701/en/
Source: Gilead Sciences, Inc.
Gilead Sciences, Inc.
Sung Lee, 650-524-7792
Investor Relations
